NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM4586558 Query DataSets for GSM4586558
Status Public on Jun 24, 2021
Title SY2_LT_1: RL lenalidomide + tazemetostat
Sample type SRA
 
Source name Diffuse large B-cell lymphoma
Organism Homo sapiens
Characteristics cell line: RL
cell type: Diffuse large B-cell lymphoma
treatment: lenalidomide + tazemetostat
Treatment protocol The following model systems were used for RNA-seq: 1) RL cells treated with DMSO, 10μM lenalidomide, 5μM tazemetostat or combination; 2) SUDHL4 cells treated with DMSO, 10μM lenalidomide, 5μM tazemetostat or combination; and 3) SUDHL4 cells with either IKZF1 knockout or LacZ gRNA control treated with DMSO or 5μM tazemetostat. Two technical replicates of all samples and conditions were prepared. Cells were incubated with drug treatments for 6 days.
Growth protocol SUDHL4 parental and engineered cell lines were grown at 37°C with 5% CO2 in RPMI 1640 supplemented with 2mM L-glutamine and 20% FBS. RL cells were cultured similarly in medium with 10% FBS.
Extracted molecule total RNA
Extraction protocol RNeasy Mini Kit (Qiagen)
Illumina TruSeq Stranded mRNA Library Prep kit
 
Library strategy RNA-Seq
Library source transcriptomic
Library selection cDNA
Instrument model NextSeq 550
 
Data processing Raw reads were mapped to hg19 using the STAR 2.7.3a two pass mode.
Gene counts were generated using "quantMode GeneCounts" from within STAR.
Genome_build: hg19
 
Submission date Jun 02, 2020
Last update date Jun 24, 2021
Contact name Robert Kridel
Organization name Princess Margaret Cancer Centre
Street address 101 College Street, Rm 12-311
City Toronto
State/province ON
ZIP/Postal code M5G 1L7
Country Canada
 
Platform ID GPL21697
Series (2)
GSE151607 Combined inhibition of EZH2 and degradation of Ikaros has synergistic effects in germinal center B-cell diffuse large B-cell lymphoma [RNA-seq]
GSE152069 Combined inhibition of EZH2 and degradation of Ikaros has synergistic effects in germinal center B-cell diffuse large B-cell lymphoma
Relations
BioSample SAMN15080956
SRA SRX8452879

Supplementary file Size Download File type/resource
GSM4586558_SY2_LT_1_gene_counts.txt.gz 245.5 Kb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap